These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 23930950

  • 1. Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.
    Ouwehand AC, ten Bruggencate SJ, Schonewille AJ, Alhoniemi E, Forssten SD, Bovee-Oudenhoven IM.
    Br J Nutr; 2014 Feb; 111(3):465-73. PubMed ID: 23930950
    [Abstract] [Full Text] [Related]

  • 2. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ, Girard SA, Floris-Vollenbroek EG, Bhardwaj R, Tompkins TA.
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
    McKenzie R, Darsley M, Thomas N, Randall R, Carpenter C, Forbes E, Finucane M, Sack RB, Hall E, Bourgeois AL.
    Vaccine; 2008 Aug 26; 26(36):4731-9. PubMed ID: 18602960
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
    Ruan X, Zhang W.
    Vaccine; 2013 Mar 01; 31(11):1458-63. PubMed ID: 23375979
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a single oral dose of a live bivalent E. coli vaccine against post-weaning diarrhea due to F4 and F18-positive enterotoxigenic E. coli.
    Nadeau É, Fairbrother JM, Zentek J, Bélanger L, Tremblay D, Tremblay CL, Röhe I, Vahjen W, Brunelle M, Hellmann K, Cvejić D, Brunner B, Schneider C, Bauer K, Wolf R, Hidalgo Á.
    Vet J; 2017 Aug 01; 226():32-39. PubMed ID: 28911838
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK, Beavis JC, Stephens JC, Greenwood J, Gewert C, Thomas N, Deary A, Casula G, Daley A, Kelly P, Randall R, Darsley MJ.
    Infect Immun; 2006 Feb 01; 74(2):1062-71. PubMed ID: 16428753
    [Abstract] [Full Text] [Related]

  • 11. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C, Louis Bourgeois A, Sack D, Walker R, DeNearing B, Brubaker J, Maier N, Fix A, Dally L, Chakraborty S, Clements JD, Saunders I, Darsley MJ.
    Vaccine; 2019 Mar 28; 37(14):1978-1986. PubMed ID: 30797634
    [Abstract] [Full Text] [Related]

  • 12. Effect of crowding stress and Escherichia coli K88+ challenge in nursery pigs supplemented with anti-Escherichia coli K88+ probiotics.
    Khafipour E, Munyaka PM, Nyachoti CM, Krause DO, Rodriguez-Lecompte JC.
    J Anim Sci; 2014 May 28; 92(5):2017-29. PubMed ID: 24663172
    [Abstract] [Full Text] [Related]

  • 13. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 28; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of a vaccine candidate expressing enterotoxigenic Escherichia coli (ETEC) adhesins for colibacillosis with a commercial vaccine using a pig model.
    Hur J, Lee JH.
    Vaccine; 2012 Jun 06; 30(26):3829-33. PubMed ID: 22507658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines.
    Harro C, Chakraborty S, Feller A, DeNearing B, Cage A, Ram M, Lundgren A, Svennerholm AM, Bourgeois AL, Walker RI, Sack DA.
    Clin Vaccine Immunol; 2011 Oct 06; 18(10):1719-27. PubMed ID: 21852546
    [Abstract] [Full Text] [Related]

  • 18. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters.
    Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N.
    Br J Nutr; 2009 Feb 06; 101(3):367-75. PubMed ID: 18634707
    [Abstract] [Full Text] [Related]

  • 19. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J, Svennerholm AM.
    Appl Microbiol Biotechnol; 2012 Mar 06; 93(6):2291-300. PubMed ID: 22350259
    [Abstract] [Full Text] [Related]

  • 20. Novel vaccine-adjuvant combination successful against bacterial diarrhea.
    Hum Vaccin Immunother; 2014 Mar 06; 10(12):3428. PubMed ID: 26052587
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.